000305638 001__ 305638
000305638 005__ 20251109023656.0
000305638 0247_ $$2doi$$a10.1002/mp.70106
000305638 0247_ $$2pmid$$apmid:41186921
000305638 0247_ $$2pmc$$apmc:PMC12584934
000305638 0247_ $$2ISSN$$a0094-2405
000305638 0247_ $$2ISSN$$a1522-8541
000305638 0247_ $$2ISSN$$a2473-4209
000305638 0247_ $$2altmetric$$aaltmetric:184124746
000305638 037__ $$aDKFZ-2025-02280
000305638 041__ $$aEnglish
000305638 082__ $$a610
000305638 1001_ $$aXiao, Fan$$b0
000305638 245__ $$aDeep learning-based synthetic-CT-free photon dose calculation in MR-guided radiotherapy: A proof-of-concept study.
000305638 260__ $$aHoboken, NJ$$bWiley$$c2025
000305638 3367_ $$2DRIVER$$aarticle
000305638 3367_ $$2DataCite$$aOutput Types/Journal article
000305638 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762420783_1579198
000305638 3367_ $$2BibTeX$$aARTICLE
000305638 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305638 3367_ $$00$$2EndNote$$aJournal Article
000305638 520__ $$aIn magnetic resonance imaging (MRI)-guided online adaptive radiotherapy, MRI lacks tissue attenuation information necessary for accurate dose calculations. Although deep learning (DL)-based synthetic computed tomography (CT) generation models have been developed to obtain CT density information from MRI, they usually do not meet the requirement of real-time plan adaptation.We propose a DL-based photon dose calculation method directly on 0.35 T MRI to skip synthetic CT generation and show its feasibility for prostate patient cases.The 0.35 T planning MRI and deformed planning CT (registered to the planning MRI) of 34 prostate cancer patients treated with a 0.35 T magnetic resonance-linear accelerator (MR-Linac) were collected. The air cavities (ACs) in the abdominopelvic area of the deformed CT images were corrected based on manual AC contouring on the MRI. Monte Carlo (MC) dose simulations under a 0.35 T magnetic field were performed on the corrected CT images. All photon beams were simulated using a uniform field size of 1 cm × 1 cm $1\,\text{cm} \times 1\,\text{cm}$ . 10 800 beams were simulated with 5 × 10 6 $5\times 10^6$ initial photons for training (20 patients) and 2160 beams with 5 × 10 7 $5\times 10^7$ photons for validation (4 patients). For testing, 1080 beams shooting through the planning target volume (PTV) in 10 patients and five optimized nine-field intensity-modulated plans were simulated with 5 × 10 7 $5\times 10^7$ photons. 3D MRI cuboids covering the photon beams were input into a Unet model to predict AC segmentation, and 3D MRI and predicted AC cuboids were input into a long short-term memory (LSTM) model for beam's eye view (BEV) processing to predict dose. The gamma passing rate γ pr $\gamma _{\mathrm{pr}}$ (2%/2mm, D > 10 % D max $D>10\%D_{\mathrm{max}}$ ), beam dose profiles of single beams and dose volume histogram (DVH) of intensity-modulated plans were evaluated.The test results for all photon beams from the proposed models demonstrated a mean γ pr $\gamma _{\mathrm{pr}}$ above 99.50%. The five treatment plans recalculated by the DL model each achieved γ pr $\gamma _{\mathrm{pr}}$ values exceeding 99.80%. Additionally, the model's inference time was approximately 12 ms per photon beam.The proposed method showed that DL-based dose calculation directly on MRI is feasible for prostate cases, which has the potential to simplify the procedure for MRI-only workflows and can be beneficial for real-time plan adaptation.
000305638 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000305638 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305638 650_7 $$2Other$$aLSTM
000305638 650_7 $$2Other$$aMRI
000305638 650_7 $$2Other$$adeep learning
000305638 650_7 $$2Other$$adose calculation
000305638 650_7 $$2Other$$aonline MR‐guided photon therapy
000305638 650_2 $$2MeSH$$aDeep Learning
000305638 650_2 $$2MeSH$$aRadiotherapy, Image-Guided: methods
000305638 650_2 $$2MeSH$$aHumans
000305638 650_2 $$2MeSH$$aMagnetic Resonance Imaging
000305638 650_2 $$2MeSH$$aPhotons: therapeutic use
000305638 650_2 $$2MeSH$$aRadiotherapy Planning, Computer-Assisted: methods
000305638 650_2 $$2MeSH$$aProof of Concept Study
000305638 650_2 $$2MeSH$$aRadiotherapy Dosage
000305638 650_2 $$2MeSH$$aProstatic Neoplasms: radiotherapy
000305638 650_2 $$2MeSH$$aProstatic Neoplasms: diagnostic imaging
000305638 650_2 $$2MeSH$$aRadiation Dosage
000305638 650_2 $$2MeSH$$aMale
000305638 650_2 $$2MeSH$$aMonte Carlo Method
000305638 650_2 $$2MeSH$$aTomography, X-Ray Computed
000305638 7001_ $$aRadonic, Domagoj$$b1
000305638 7001_ $$0P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336$$aWahl, Niklas$$b2$$udkfz
000305638 7001_ $$aDelopoulos, Nikolaos$$b3
000305638 7001_ $$aThummerer, Adrian$$b4
000305638 7001_ $$aCorradini, Stefanie$$b5
000305638 7001_ $$0P:(DE-HGF)0$$aBelka, Claus$$b6
000305638 7001_ $$aDedes, George$$b7
000305638 7001_ $$aKurz, Christopher$$b8
000305638 7001_ $$aLandry, Guillaume$$b9
000305638 773__ $$0PERI:(DE-600)1466421-5$$a10.1002/mp.70106$$gVol. 52, no. 11, p. e70106$$n11$$pe70106$$tMedical physics$$v52$$x0094-2405$$y2025
000305638 909CO $$ooai:inrepo02.dkfz.de:305638$$pVDB
000305638 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000305638 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000305638 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000305638 9141_ $$y2025
000305638 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-13$$wger
000305638 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMED PHYS : 2022$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-13
000305638 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-13
000305638 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lE040 Med. Physik in der Strahlentherapie$$x0
000305638 9201_ $$0I:(DE-He78)MU01-20160331$$kMU01$$lDKTK Koordinierungsstelle München$$x1
000305638 980__ $$ajournal
000305638 980__ $$aVDB
000305638 980__ $$aI:(DE-He78)E040-20160331
000305638 980__ $$aI:(DE-He78)MU01-20160331
000305638 980__ $$aUNRESTRICTED